Global Vaccine Administration Devices Market– Industry Trends and Forecast to 2029

Global Vaccine Administration Devices Market, By Product (Syringes, Auto Injectors, Jet Injectors, Micro Needles, Inhalation/Pulmonary Delivery, Microinjection System, Pen Injector Devices, Biodegradable Implants, Electroporation-Based Needle Free Injection Systems, Buccal /Sublingual Vaccine Delivery Systems, Auto-Injector Trainer Devices and Others Devices), Route of Administration (Intramuscular, Subcutaneous, Intradermal), Type (Marketed Vaccines and Clinical-Stage Vaccines (Electroporation)), Brand (BD Accuspray Nasal Spray System, BD Hypak for Vaccines Glass Pre-Fillable Syringe System, BD Uniject Auto-Disable Pre-Fillable Injection System, Gx InnoSafe, Gx RTF ClearJect, Plajex, Others), Dosage (Fixed and Variable), Vaccine Type (Bivalent Oral PolioVaccine, BCG Vaccine, Tetanus-Diphtheria Vaccine, DTP-HEPB-HIB Vaccine, Influenza Vaccine, Pneumococcal Conjugate Vaccine, Measles Vaccine, Others), Modality (Automatic Vaccine Administration Device and Manual Vaccine Administration Device), Usability (Disposable and Reusable), End User (Hospitals, Community Centers, Homecare Setting, Research and Academic Institutes, Ambulatory Surgical Center, Others), Distribution Channel (Direct Tenders, Retail Sales, Others) – Industry Trends and Forecast to 2029.

Vaccine Administration Devices Market Analysis and Size

One of the primary factors driving the vaccine administration devices market is the increased awareness of immunization by WHO and many governments and NGOs throughout the world. Diabetic patients are becoming more common over the world. The epidemic of COVID-19 has had a positive impact on the market. A vaccination is a biological substance that gives active acquired immunity against a specific infectious disease. The global demand for COVID-19 vaccine offers a substantial opportunity for growth, greatly helping the industry.

Data Bridge Market Research analyses a growth in the global vaccine administration devices market in the forecast period 2022-2029. The expected CAGR of global vaccine administration devices market tends to be around 7.9% in the mentioned forecast period. The market was valued at USD 3.7 billion in 2021, and it would grow upto USD 6.80 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Vaccine Administration Devices Market Scope and Segmentation

Market Definition

Vaccines are biological preparations that protect humans from viruses and bacteria-related infections. Some vaccine kinds are inactivated/killed vaccinations, live/attenuated vaccines, toxoid vaccines, and conjugate vaccines. Using a syringe or needle, vaccines are administered intramuscularly or subcutaneously. Needle-free technologies are unique vaccine administration technologies because they are effective in mass immunization programs, decreasing the risk of needle stick injuries and the consequences of many needles use. Disposable syringes, jet injectors, micro-needles, and intradermal delivery devices for inactivated poliovirus vaccines are among the additional vaccine administration methods.

Global Vaccine Administration Devices Market Dynamics

Drivers

• Increasing Production Capacity

To accommodate the rising worldwide demand, manufacturers are increasing their production capacity. The demand for packaging materials is predicted to rise as production capacity increases. AstraZeneca, for example, partnered with IDT Biologika to develop a new manufacturing plant in Germany in February 2021. IDT biology is a German contract research organization that also manufactures and fills glass vials. The rate at which the virus evolves into a more infectious strain is expected to increase vaccine demand, pushing market growth. Thus, it is helpful in driving market growth.

• Increased Alliance and immunization programs

Increasing immunization programs, rapid growth in immunization initiatives and campaigns, and rising disease rates worldwide are driving the market. For instance, the GAVI Alliance and the Bill & Melinda Gates Foundation are actively involved in immune campaigns, which should significantly improve vaccine administration devices market.

Opportunities

• Rising needle free technology

The needleless delivery system is the most important factor contributing to the growth of the vaccine administration device market. These systems have the potential to reduce the dose of vaccine antigens and improve the immunogenicity of the vaccine. Rapid technological advances such as micro-needling and electroporation are expected to boost the growth of the vaccine administration devices market. The increased use of microneedles is due to the patient's demand for painless self-administration. Vaccines administered to the dermis via microneedles act faster than intramuscular injections and drive market growth. However, one of market growth's main drivers is microneedles' cost, especially in emerging markets.

• Increased Diabetic Patients

The number of diabetic patients worldwide is increasing at a faster rate. According to the WHO, 422 million people globally are affected by the condition, which is expected to boost the market throughout the forecast period.

Restraints/Challenges

• Chances of Infection

The vaccine administration devices market is surely growing at a higher pace but there are associated infections. These side-effects can lower the market growth abruptly.

• Lack of skilled professionals

Untrained professionals who are unable to execute these vaccine administrations can surely hinder the market growth.

This vaccine administration devices market provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vaccine administration devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Vaccine Administration Devices Market

The COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period. The global demand for COVID-19 vaccination provided a major chance for expansion, benefiting the market significantly. It is flourishing well in the post-pandemic era as the number of people willing to take vaccination is increasing, thus boosting the market growth.

Market Developments

• In June 2021, PharmaJet started enrolment for a needle-free COVID-19 vaccine trial.
• In November 2020, Mylan NV transformed into Viatris, the global drug manufacturer formed with the merger of Mylan and the Upjohn division of Pfizer Inc.

Global Vaccine Administration Devices Market Scope

The global vaccine administration devices market is segmented on the basis of product, route of administration, type, brand, dosage, vaccine type, modality, usability, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Syringes
• Auto Injectors
• Jet Injectors
• Micro Needles
• Inhalation/Pulmonary Delivery
• Microinjection System
• Pen Injector Devices
• Biodegradable Implants
• Electroporation-Based Needle Free Injection Systems
• Buccal /Sublingual Vaccine Delivery Systems
• Auto-Injector Trainer Devices
• Others Devices

Route of Administration

• Intramuscular
• Subcutaneous
• Intradermal

Type

• Marketed Vaccines
• Clinical-Stage Vaccines (Electroporation)

Brand

• BD Accuspray Nasal Spray System
• BD Hypak for Vaccines Glass Pre-Fillable Syringe System
• BD Uniject Auto-Disable Pre-Fillable Injection System
• Gx InnoSafe
• Gx RTF ClearJect, Plajex
• Others

Dosage

• Fixed
• Variable

Vaccine Type

• Bivalent Oral PolioVaccine
• BCG Vaccine
• Tetanus-Diphtheria Vaccine
• DTP-HEPB-HIB Vaccine
• Influenza Vaccine
• Pneumococcal Conjugate Vaccine
• Measles Vaccine
• Others

Modality

• Automatic Vaccine Administration Device
• Manual Vaccine Administration Device

Usability

• Disposable
• Reusable

End User

• Hospitals
• Community Centers
• Homecare Setting
• Research and Academic Institutes
• Ambulatory Surgical Center
• Others

Distribution Channel

• Direct Tenders
• Retail Sales
• Others

Vaccine Administration Devices Market Regional Analysis/Insights

The vaccine administration devices market is analyzed and market size insights and trends are provided by country, product, route of administration, type, brand, dosage, vaccine type, modality, usability, end user, and distribution channel as referenced above.

The major countries covered in the vaccine administration devices market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the vaccine administration devices market due to growing immunization coverage and increasing investments in R&D for new vaccines.

Asia-Pacific is expected to grow at a significant growth rate during the forecast period of 2022 to 2029 due to rapidly improving infrastructure in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Vaccine Administration Devices Market Share Analysis

The vaccine administration devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to vaccine administration devices market

Key players operating in the vaccine administration devices market include:

• B.D. (U.S.)
• INOVIO Pharmaceuticals (U.S.)
• Vaxxas (U.S.)
• Gerresheimer AG (Germany)
• Corium Inc. (U.S.)
• Enesi (U.S.)
• Micropoint Technologies (Singapore)
• SCHOTT AG (Germany)
• 3M (U.S.)
• Mystic Pharmaceuticals (U.S.)
• NanoPass Rev (US)
• Terumo Europe NV (Belgium)
• D'Antonio Consultants International, Inc. (U.S.)
• West Pharmaceutical Services, Inc. (U.S.).
• Mylan N.V. (U.S.)
• Medical International Technologies Inc. (Canada)
• Antares Pharma (U.S.)